Search Results - "MASEREEUW, R."

Refine Results
  1. 1

    Bioengineered kidney tubules efficiently excrete uremic toxins by Jansen, J., Fedecostante, M., Wilmer, M. J., Peters, J. G., Kreuser, U. M., van den Broek, P. H., Mensink, R. A., Boltje, T. J., Stamatialis, D., Wetzels, J. F., van den Heuvel, L. P., Hoenderop, J. G., Masereeuw, R.

    Published in Scientific reports (31-05-2016)
    “…The development of a biotechnological platform for the removal of waste products (e.g. uremic toxins), often bound to proteins in plasma, is a prerequisite to…”
    Get full text
    Journal Article
  2. 2

    Iron metabolism in the pathogenesis of iron-induced kidney injury by Martines, A. M. F., Masereeuw, R., Tjalsma, H., Hoenderop, J. G., Wetzels, J. F. M., Swinkels, D. W.

    Published in Nature reviews. Nephrology (01-07-2013)
    “…Patients with kidney disease are often exposed to high concentrations of iron as a result of the underlying pathological processes. Under these conditions,…”
    Get full text
    Journal Article
  3. 3

    Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate by Peters, E, Geraci, S, Heemskerk, S, Wilmer, M J, Bilos, A, Kraenzlin, B, Gretz, N, Pickkers, P, Masereeuw, R

    Published in British journal of pharmacology (01-10-2015)
    “…Background and Purpose Recently, two phase‐II trials demonstrated improved renal function in critically ill patients with sepsis‐associated acute kidney injury…”
    Get full text
    Journal Article
  4. 4

    The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane by Huls, M., Brown, C.D.A., Windass, A.S., Sayer, R., van den Heuvel, J.J.M.W., Heemskerk, S., Russel, F.G.M., Masereeuw, R.

    Published in Kidney international (01-01-2008)
    “…The Breast Cancer Resistance Protein (BCRP/ABCG2) is a transporter restricting absorption and enhancing excretion of many compounds including anticancer drugs…”
    Get full text
    Journal Article
  5. 5

    KCNJ16-depleted kidney organoids recapitulate tubulopathy and lipid recovery upon statins treatment by Sendino Garví, E, van Slobbe, G J J, Zaal, E A, de Baaij, J H F, Hoenderop, J G, Masereeuw, R, Janssen, M J, van Genderen, A M

    Published in Stem cell research & therapy (26-08-2024)
    “…The KCNJ16 gene has been associated with a novel kidney tubulopathy phenotype, viz. disturbed acid-base homeostasis, hypokalemia and altered renal salt…”
    Get full text
    Journal Article
  6. 6

    Development of an adverse outcome pathway network for nephrotoxicity by Barnes, D. A., Firman, J. W., Belfield, S. J., Cronin, M. T. D., Vinken, M., Janssen, M. J., Masereeuw, R.

    Published in Archives of toxicology (01-03-2024)
    “…Adverse outcome pathways (AOPs) were introduced in modern toxicology to provide evidence-based representations of the events and processes involved in the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Inhibition of Nrf2 alters cell stress induced by chronic iron exposure in human proximal tubular epithelial cells by van Raaij, S.E.G., Masereeuw, R., Swinkels, D.W., van Swelm, R.P.L.

    Published in Toxicology letters (01-10-2018)
    “…•Chronic renal iron exposure in systemic iron overload can induce injury.•Iron loading activates the antioxidative Nrf2 pathway and its target genes.•Chronic…”
    Get full text
    Journal Article
  9. 9

    Combining Extracellular miRNA Determination with Microfluidic 3D Cell Cultures for the Assessment of Nephrotoxicity: a Proof of Concept Study by Suter-Dick, Laura, Mauch, L., Ramp, D., Caj, M., Vormann, M. K., Hutter, S., Lanz, H. L., Vriend, J., Masereeuw, R., Wilmer, M. J.

    Published in The AAPS journal (01-09-2018)
    “…Drug-induced kidney injury is often observed in the clinics and can lead to long-term organ failure. In this work, we evaluated a novel in vitro system that…”
    Get full text
    Journal Article
  10. 10

    Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration by Mutsaers, H A M, Wilmer, M J G, Reijnders, D, Jansen, J, van den Broek, P H H, Forkink, M, Schepers, E, Glorieux, G, Vanholder, R, van den Heuvel, L P, Hoenderop, J G, Masereeuw, R

    Published in Biochimica et biophysica acta (01-01-2013)
    “…During chronic kidney disease (CKD), drug metabolism is affected leading to changes in drug disposition. Furthermore, there is a progressive accumulation of…”
    Get full text
    Journal Article
  11. 11

    Vascular units as advanced living materials for bottom-up engineering of perfusable 3D microvascular networks by Orge, I.D., Nogueira Pinto, H., Silva, M.A., Bidarra, S.J., Ferreira, S.A., Calejo, I., Masereeuw, R., Mihăilă, S.M., Barrias, C.C.

    Published in Bioactive materials (01-08-2024)
    “…The timely establishment of functional neo-vasculature is pivotal for successful tissue development and regeneration, remaining a central challenge in tissue…”
    Get full text
    Journal Article
  12. 12

    A morphological and functional comparison of proximal tubule cell lines established from human urine and kidney tissue by Jansen, J., Schophuizen, C.M.S., Wilmer, M.J., Lahham, S.H.M., Mutsaers, H.A.M., Wetzels, J.F.M., Bank, R.A., van den Heuvel, L.P., Hoenderop, J.G., Masereeuw, R.

    Published in Experimental cell research (15-04-2014)
    “…Promising renal replacement therapies include the development of a bioartificial kidney using functional human kidney cell models. In this study, human…”
    Get full text
    Journal Article
  13. 13

    Biotechnological challenges of bioartificial kidney engineering by Jansen, J., Fedecostante, M., Wilmer, M.J., van den Heuvel, L.P., Hoenderop, J.G., Masereeuw, R.

    Published in Biotechnology advances (15-11-2014)
    “…With the world-wide increase of patients with renal failure, the development of functional renal replacement therapies have gained significant interest and…”
    Get full text
    Journal Article
  14. 14

    A bioartificial kidney device with polarized secretion of immune modulators by Chevtchik, N. V., Mihajlovic, M., Fedecostante, M., Bolhuis‐Versteeg, L., Sastre Toraño, J., Masereeuw, R., Stamatialis, D.

    “…The accumulation of protein‐bound toxins in dialyzed patients is strongly associated with their high morbidity and mortality. The bioartificial kidney device…”
    Get full text
    Journal Article
  15. 15

    Mild intracellular acidification by dexamethasone attenuates mitochondrial dysfunction in a human inflammatory proximal tubule epithelial cell model by Schirris, T. J. J., Jansen, J., Mihajlovic, M., van den Heuvel, L. P., Masereeuw, R., Russel, F. G. M.

    Published in Scientific reports (06-09-2017)
    “…Septic acute kidney injury (AKI) associates with poor survival rates and often requires renal replacement therapy. Glucocorticoids may pose renal protective…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    ABC transporter expression profiling after ischemic reperfusion injury in mouse kidney by Huls, M., van den Heuvel, J.J.M.W., Dijkman, H.B.P.M., Russel, F.G.M., Masereeuw, R.

    Published in Kidney international (01-06-2006)
    “…Renal ATP binding cassette (ABC) transporters have an important role in the elimination of metabolic waste products and compounds foreign to the body. The…”
    Get full text
    Journal Article
  19. 19

    G.P.108 by den Besten, C, Jones, S, Wilmer, M, Masereeuw, R, Campion, G

    Published in Neuromuscular disorders : NMD (01-10-2014)
    “…Prosensa Therapeutics is developing 2′ O -modified phosphorothioate antisense oligonucleotides (AONs) to provide a mutation-specific therapy in the treatment…”
    Get full text
    Journal Article
  20. 20